Cargando…
Corrigendum: Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations With Amyloid Peptides Aß(1−42), and Tau Proteins in Elderly Patients With Mild Cognitive Impairment
Autores principales: | Duron, Emmanuelle, Vidal, Jean-Sébastien, Grousselle, Dominique, Gabelle, Audrey, Lehmann, Sylvain, Pasquier, Florence, Bombois, Stéphanie, Buée, Luc, Allinquant, Bernadette, Schraen-Maschke, Susanna, Baret, Christiane, Rigaud, Anne-Sophie, Hanon, Olivier, Epelbaum, Jacques |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390179/ https://www.ncbi.nlm.nih.gov/pubmed/30837862 http://dx.doi.org/10.3389/fnagi.2019.00011 |
Ejemplares similares
-
Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations With Amyloid Peptides Aβ(1–42) and Tau Proteins in Elderly Patients With Mild Cognitive Impairment
por: Duron, Emmanuelle, et al.
Publicado: (2018) -
Plasma phosphorylated tau 181 predicts amyloid status and conversion to dementia stage dependent on renal function
por: Lehmann, Sylvain, et al.
Publicado: (2023) -
Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study
por: Dumurgier, Julien, et al.
Publicado: (2015) -
Association of Plasma Aß Peptides with Blood Pressure in the Elderly
por: Lambert, Jean-Charles, et al.
Publicado: (2011) -
Central Nervous System and Peripheral Inflammatory Processes in Alzheimer’s Disease: Biomarker Profiling Approach
por: Delaby, Constance, et al.
Publicado: (2015)